Image Image Image Image Image Image Image Image Image Image
Доступ
Идти наверх

Идти наверх

As-needed treatment with ranibizumab 0.5 mg in patients with neovascular age-related macular degeneration. (FALTA)
26/03/2013

Last modified: 26 July, 2019 - 12:38